A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Clinical trial NCT07009262 · COMPLETED

Trial details

NCT number: NCT07009262
Sponsor: KalVista Pharmaceuticals, Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema

Start date: 2025-04-21
Primary completion: 2025-11-25
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.